Tower Research Capital LLC (Trc) In Med Pharmaceuticals Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
Shares
1 transactions
Others Institutions Holding INM
# of Institutions
19Shares Held
686KCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ362KShares$97,6664.44% of portfolio
-
Armistice Capital, LLC New York, NY267KShares$72,0810.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny28.3KShares$7,6410.0% of portfolio
-
Two Sigma Securities, LLC New York, NY15.4KShares$4,1640.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.7KShares$3,4350.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $245K
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...